Transplanted Ptpn2-/- T cells better protect older Tp53+/− mice from developing tumors and hinder the growth of transplanted mammary cancer, resulting in an increased presence of activated CD4+ and CD8+ effector and memory T cells in the tumor (59). Here, PTPN2 is linked to neoplasm.